Skip to main content
OpenTrials
Completed

NCT Number: NCT02247934

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Colorado Hospital, Denver Health Medical Center, Aurora, Colorado, United States

Loading trial locations.

About this study

In Step I, concept elicitation one-on-one interviews (via telephone or in person) will be conducted. The aims of the concept elicitation interviews are to:

  • Identify the most common symptoms, as well as the most important symptoms, for patients with PSC, and
  • Assess whether these symptoms impact day-to-day functioning

An instrument will be developed based on the symptoms reported and in Step II of the study, the performance of the instrument will be assessed with further interviews.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of PSC based on liver biopsy or diagnostic imaging, with diagnosis made at least three months prior to screening
  • Patient report of PSC symptoms associated with PSC diagnosis
  • Able to speak, read, and understand English
  • Willing and able to provide written informed consent to participate in the research study

Exclusion criteria

  • Patients with other causes of liver or biliary disease, including viral hepatitis, alcoholic liver disease, primary biliary cirrhosis, and secondary sclerosing cholangitis
  • Patient with history of liver cirrhosis
  • Patients with history of cholangiocarcinoma
  • Patients who have received a liver transplant
  • Patients currently enrolled in PSC clinical trials; and
  • STEP II ONLY: Enrolled in or participated in Step I of this study (concept elicitation)

Treatment and study plan

Primary outcomes

  1. List Primary Sclerosing Cholangitis (PSC) Symptoms for inclusion in patient questionnaire

    Time frame: Up to 12 months

    Interview participants to generate a list of the most common symptoms, as well as the most important symptoms, experienced by patients with PSC, and whether each symptom impacts day-to-day functioning.

Sponsors and collaborators

Lead sponsor

Gilead Sciences

Industry

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Sep 25, 2014
Registry last updated
Feb 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.